BeiGene Initiates Pivotal Trial of PARP inhibitor Pamiparib (BGB-290) in China in Patients With Ovarian Cancer Dec 18, 2017 Life Science
GBIL Pays $29 Million to Acquire Surgical Robot for China from TransEnterix Dec 18, 2017 Life Science
Teva Pharmaceutical shares jump after Goldman upgrades embattled drugmaker, predicts turnaround Dec 15, 2017 Life Science
Life Science & Technology Weekly 125 – Forum highlights investment in life science, high tech Dec 14, 2017 Life Science, Technology
China’s still in a bull market despite recent wobbles, analyst says Dec 11, 2017 Financial Service, Life Science
BGI Genomics Partners with Sanguine to Build Databases of Clinical Trial Patients Dec 8, 2017 Life Science
Chinese company wins second prize in Prince Andrew’s startup contest Dec 7, 2017 Life Science, Technology
Life Science & Technology Weekly 124 – Everest Enters $224 Million Two-Drug China Partnership with Arena Dec 7, 2017 Life Science, Technology
Wuxi Biologics Initiated CGMP Manufacturing In The World’S Largest Biologics Manufacturing Facility Using Only Single-Use Bioreactors Dec 6, 2017 Life Science
